Keros Therapeutics, Inc.

The current price of KROS is 58.28 USD — it has decreased by 1.14% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Keros Therapeutics, Inc. stocks are traded under the ticker KROS.

Keros Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

KROS stock is 6.68% volatile and has beta coefficient of 0.64. Check out the list of the most volatile stocks — is Keros Therapeutics, Inc. there?

One year price forecast for Keros Therapeutics, Inc. has a max estimate of 105.00 USD and a min estimate of 77.00 USD.

KROS earnings for the last quarter are −1.33 USD per share, whereas the estimation was −1.35 USD resulting in a 1.34% surprise. The estimated earnings for the next quarter are −1.37 USD per share. See more details about Keros Therapeutics, Inc. earnings.

Keros Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪325.00 K‬ USD. In the next quarter revenue is expected to reach ‪216.67 K‬ USD.

Yes, you can track Keros Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

KROS net income for the last quarter is ‪−40.24 M‬ USD, while the quarter before that showed ‪−39.44 M‬ USD of net income which accounts for −2.04% change. Track more Keros Therapeutics, Inc. financial stats to get the full picture.

Today Keros Therapeutics, Inc. has the market capitalization of ‪2.12 B‬, it has decreased by 1.30% over the last week.

No, KROS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, KROS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Keros Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

KROS reached its all-time high on Dec 8, 2020 with the price of 88.80 USD, and its all-time low was 19.10 USD and was reached on Apr 8, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 136.00 employees. See our rating of the largest employees — is Keros Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Keros Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Keros Therapeutics, Inc. stock shows the buy signal. See more of Keros Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Keros Therapeutics, Inc. future price: according to them, KROS price has a max estimate of 105.00 USD and a min estimate of 77.00 USD. Read a more detailed Keros Therapeutics, Inc. forecast: see what analysts think of Keros Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Keros Therapeutics, Inc. EBITDA is ‪−167.91 M‬ USD, and current EBITDA margin is ‪−112.00 K‬%. See more stats in Keros Therapeutics, Inc. financial statements.